Selected article for: "CoV surface protein and surface protein"
Author: Jerome R Lon; Yunmeng Bai; Bingxu Zhong; Fuqiang Cai; Hongli Du
Title: Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2
  • Document date: 2020_4_5
    • ID: fmumym1x_3
    Snippet: In this work, we analyzed the surface protein of SARS-CoV-2, predicted the structures with bioinformatics methods. On the basis, we predicted the linear and conformational B cell epitopes, analyzed the conservation of the epitopes, the adaptability and other evolutionary characteristics of the surface protein, which provided a theoretical basis for the vaccine development and prevention of SARS-CoV-2......
    Document: In this work, we analyzed the surface protein of SARS-CoV-2, predicted the structures with bioinformatics methods. On the basis, we predicted the linear and conformational B cell epitopes, analyzed the conservation of the epitopes, the adaptability and other evolutionary characteristics of the surface protein, which provided a theoretical basis for the vaccine development and prevention of SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • cell epitope and epitope conservation: 1, 2, 3, 4, 5, 6
    • cell epitope and SARS surface protein: 1, 2, 3, 4
    • cell epitope and surface protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • cell epitope and theoretical basis: 1
    • cell epitope and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • epitope conservation and vaccine development: 1, 2, 3, 4, 5, 6
    • prevention vaccine development and SARS prevention vaccine development: 1, 2, 3
    • prevention vaccine development and SARS surface protein: 1
    • prevention vaccine development and surface protein: 1, 2
    • prevention vaccine development and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • SARS prevention vaccine development and vaccine development: 1, 2, 3, 4
    • SARS surface protein and surface protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • SARS surface protein and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • surface protein and theoretical basis: 1, 2
    • surface protein and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • theoretical basis and vaccine development: 1, 2, 3, 4, 5